Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Keywords: Chronic obstructive pulmonary disease (COPD) NVA237
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 460
Healthy volunteers: no

Brief summary:
This study will assess of the efficacy and safety of a once-daily, 50µg inhalation of NVA237 in moderate to severe chronic obstructive pulmonary disease (COPD) patients over 26 weeks treatment.

Detailed description:

Arms:
arm 1: NVA237 50 µg once daily delivered via a single dose dry powder inhaler arm 2: Placebo once daily delivered via a single dose dry powder inhaler

Interventions: intervention 1: NVA237 intervention 2: Placebo
Intervention descriptions: intervention 1: Delivered via a single dose dry powder inhaler intervention 2: Delivered via a single dose dry powder inhaler

Protocol document: